
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
Treatment research reached a fever pitch in the final months of last year. The first oral entry inhibitor, Selzentry, was approved by the Food and Drug Administration, as was Isentress, the first drug to emerge in the new integrase inhibitor class. And just days into this year, Intelence, a second-generation nonnucleoside, received the FDA's nod. But in recent months news of advancements, like those milestones, has quieted, and a close look at the development pipeline shows that the immediate future is going to be uneventful indeed. Although there are 149 different compounds being studied, none will reach the market this year. In fact, while there are 27 experimental medications in clinical trials, none are in Phase III human trials'the final stage of research before FDA approval is sought'and only seven are in full Phase II efficacy studies. The upside is that, although there will be no new anti-HIV drugs approved in the foreseeable future, the medications that are the farthest along in development offer significant benefits over existing medications by attacking the virus in new ways, being more potent than similar drugs, producing fewer side effects, or being taken less frequently. The obvious downside is that most are still years away. DRUGS IN HUMAN STUDIESEntry Inhibitors: HGS004 (CCR5 blocker antibody), Phase I/II, Human Genome Sciences INCB9471 (CCR5 blocker), Phase II, Incyte PF232798 (CCR5 blocker), Phase I, Pfizer PRO140 (CCR5 blocker antibody), Phase I/II, Progenics Suc-HSA (gp120 blocker), Phase I, Sanquin TAK220 (CCR5 blocker), Phase I, Tobira (licensed from Takeda) TAK652 (CCR5 blocker), Phase I, Tobira (licensed from Takeda) TNX355 (CD4 blocker antibody), Phase II, Tanox and Biogen Vicriviroc (CCR5 blocker), Phase II, Schering-Plough Integrase Inhibitors: Elvitegravir (GS9137) , Phase II, Gilead Sciences GSK364735, Phase I, GlaxoSmithKline/Shionogi Nonnucleoside Reverse Transcriptase Inhibitors: 70h (GW678248), Phase I, GlaxoSmithKline BILR 355/r BS, Phase I/II, Boehringer Ingelheim Rilpivirine (TMC278), Phase II, Tibotec UK435061, Phase I/II, Pfizer Nucleoside Reverse Transcriptase Inhibitors: Amdoxovir, Phase II, RFS Pharma Apricitabine (AVX754), Phase I/II, Avexa DOT (dioxolane thymidine), Phase I, University of Georgia Elvucitabine (ACH126), Phase I/II, Achillion Fosalvudine (alovudine prodrug), Phase I/II, Heidelberg Pharmaceuticals Racivir, Phase I/II, Pharmasset Protease Inhibitors: PPL100, Phase I, Merck SPI452, Phase I, Sequoia Pharmaceuticals Other Classes: Bevirimat (PA457) (maturation inhibitor), Phase II, Panacos BI201 (anti-tat antibody), Phase I, BioInvent KP1461 (viral decay accelerator), Phase I/II, Koronis PA1050040 (gag processing inhibitor), Phase 1, Panacos
From our Sponsors
Most Popular
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
Grindr is reminding us why jockstraps are so sexy and iconic
May 02 2025 5:36 PM
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
Plus: Featured Video
Latest Stories
BREAKING: Supreme Court rules to save free access to preventive care, including PrEP
June 27 2025 10:32 AM
1985: the year the AIDS crisis finally broke through the silence
June 26 2025 11:24 AM
VIDEO: A man living with HIV discusses his journey to fatherhood
June 10 2025 4:58 PM
Trump admin guts $258 million in funding for HIV vaccine research
June 03 2025 3:47 PM
HRC holds 'die-in' to protest Trump health care cuts
April 28 2025 2:11 PM
Two right-wing Supreme Court justices signal they may uphold access to PrEP and more
April 21 2025 4:10 PM
500,000 Children at Risk: PEPFAR Funding Crisis
April 08 2025 3:51 PM
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Decades of progress, uniting to fight HIV/AIDS
December 01 2024 12:30 PM